Semin Thromb Hemost 2024; 50(06): 851-865
DOI: 10.1055/s-0043-1777991
Review Article

Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

Behnood Bikdeli*
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
3   YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut
4   Cardiovascular Research Foundation (CRF), New York, New York
,
Parham Sadeghipour*
5   Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran
6   Clinical Trial Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Junyang Lou
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Antoine Bejjani
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Candrika D. Khairani
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Sina Rashedi
5   Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Robert Lookstein
7   Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
,
Alexandra Lansky
8   Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut
,
Suresh Vedantham
9   Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri
,
Piotr Sobieszczyk
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Carlos Mena-Hurtado
8   Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut
,
Ayaz Aghayev
10   Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Peter Henke
11   Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan
,
Ghazaleh Mehdipoor
4   Cardiovascular Research Foundation (CRF), New York, New York
12   Center for Evidence-based Imaging, Brigham and Women's Hospital, Boston, Massachusetts
,
Antonella Tufano
13   Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
,
Saurav Chatterjee
14   Division of Cardiology, Department of Medicine, Zucker School of Medicine, New York, New York
,
Saskia Middeldorp
15   Department of Internal Medicine, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands
,
Suman Wasan
16   University of North Carolina, Chapel Hill, North Carolina
,
Riyaz Bashir
17   Departement of Cardiovascular Diseases, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
,
Irene M. Lang
18   Department of Internal Medicine II, Cardiology and Center of Cardiovascular Medicine, Medical University of Vienna, Vienna, Austria
,
Mehdi H. Shishehbor
19   University Hospitals Heath System, Harrington Heart and Vascular Institute, Cleveland, Ohio
,
Marie Gerhard-Herman
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Jay Giri
20   Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Cardiovascular Division, University of Pennsylvania, Philadelphia, Pennsylvania
,
Matthew T. Menard
21   Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Sahil A. Parikh
4   Cardiovascular Research Foundation (CRF), New York, New York
22   Division of Cardiology, New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York
,
Lucia Mazzolai
23   Division of Angiology, Heart and Vessel Department, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
,
Lisa Moores
24   Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, Maryland
,
Manuel Monreal
25   Universidad Católica San Antonio de Murcia, Spain
,
David Jimenez
26   Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain
27   Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain
28   CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain
,
Samuel Z. Goldhaber
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Harlan M. Krumholz
3   YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut
8   Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut
29   Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut
,
Gregory Piazza
1   Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Funding Dr. Bikdeli is supported by the Scott Schoen and Nancy Adams IGNITE Award, and the Mary Ann Tynan Research Scientist award through the Mary Horrigan Connors Center for Women's Health and Gender Biology, as well as the Heart and Vascular Center Junior Faculty Award, all at Brigham and Women's Hospital. Dr. Bikdeli is a recipient of a Career Development Award from the American Heart Association and VIVA Physicians (#938814). No funding was received for the preparation of this study.

Abstract

The inferior vena cava (IVC) and superior vena cava are the main conduits of the systemic venous circulation into the right atrium. Developmental or procedural interruptions of vena cava might predispose to stasis and deep vein thrombosis (DVT) distal to the anomaly and may impact the subsequent rate of pulmonary embolism (PE). This study aimed to review the various etiologies of developmental or procedural vena cava interruption and their impact on venous thromboembolism. A systematic search was performed in PubMed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines per each clinical question. For management questions with no high-quality evidence and no mutual agreements between authors, Delphi methods were used. IVC agenesis is the most common form of congenital vena cava interruption, is associated with an increased risk of DVT, and should be suspected in young patients with unexpected extensive bilateral DVT. Surgical techniques for vena cava interruption (ligation, clipping, and plication) to prevent PE have been largely abandoned due to short-term procedural risks and long-term complications, although survivors of prior procedures are occasionally encountered. Vena cava filters are now the most commonly used method of procedural interruption, frequently placed in the infrarenal IVC. The most agreed-upon indication for vena cava filters is for patients with acute venous thromboembolism and coexisting contraindications to anticoagulation. Familiarity with different forms of vena cava interruption and their local and systemic adverse effects is important to minimize complications and thrombotic events.

Authors' Contributions

Drs. Bikdeli and Sadeghipour contributed equally to this submission. Drs. Bikdeli, Sadeghipour, Lou, and Piazza prepared the outlines of the submission and had the primary role to prepare a first draft with help from Drs. Bejjani, Khairani, Rashedi, and Piazza. Dr. Chatterjee shared additional expert input about meta-analyses reported in this article. All other coauthors reviewed the initial outlines of the review, as well as subsequent drafts of the review, contributed to the concept and design of the study, shared intellectual input, critical edits, and comments, and approved the final version.


* Dr. Bikdeli and Dr. Sadeghipour contributed equally to this article.


Supplementary Material



Publication History

Article published online:
04 January 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Koc Z, Oguzkurt L. Interruption or congenital stenosis of the inferior vena cava: prevalence, imaging, and clinical findings. Eur J Radiol 2007; 62 (02) 257-266
  • 2 Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev 2005; 19 (04) 179-202
  • 3 Nakakubo S, Makizako H, Doi T. et al. Long and short sleep duration and physical frailty in community-dwelling older adults. J Nutr Health Aging 2018; 22 (09) 1066-1071
  • 4 Adams JT, DeWeese JA. Creation of the Adams-DeWeese inferior vena cava clip. J Vasc Surg 2011; 53 (06) 1745-1747
  • 5 Homans J. Venous thrombosis and pulmonary embolism. N Engl J Med 1947; 236 (06) 196-201
  • 6 Payne JT. Indications for ligation of the inferior vena cava in venous thrombosis. AMA Arch Surg 1953; 67 (06) 902-915
  • 7 Bikdeli B, Chatterjee S, Desai NR. et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J Am Coll Cardiol 2017; 70 (13) 1587-1597
  • 8 Mir MA. Superior vena cava filters: hindsight, insight and foresight. J Thromb Thrombolysis 2008; 26 (03) 257-261
  • 9 Shin DS, Sandstrom CK, Ingraham CR, Monroe EJ, Johnson GE. The inferior vena cava: a pictorial review of embryology, anatomy, pathology, and interventions. Abdom Radiol (NY) 2019; 44 (07) 2511-2527
  • 10 Ramanathan T, Hughes TM, Richardson AJ. Perinatal inferior vena cava thrombosis and absence of the infrarenal inferior vena cava. J Vasc Surg 2001; 33 (05) 1097-1099
  • 11 Bronshtein M, Khatib N, Blumenfeld Z. Prenatal diagnosis and outcome of isolated interrupted inferior vena cava. Am J Obstet Gynecol 2010; 202 (04) 398.e1-398.e4
  • 12 Meyer DR. Segmentale Varianten der Vena cava inferior Erscheinungsbild mit embryologischer Korrelation in abgrenzung zum sekundaren Vena-cava-Verschluss. Rontgenpraxis 2001; 54: 101-113
  • 13 Tufano A, López-Jiménez L, Bikdeli B. et al; RIETE Investigators. Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspect. Int J Cardiol 2020; 305: 115-119
  • 14 Tarango C, Kumar R, Patel M, Blackmore A, Warren P, Palumbo JS. Inferior vena cava atresia predisposing to acute lower extremity deep vein thrombosis in children: a descriptive dual-center study. Pediatr Blood Cancer 2018; 65 (02) e26785
  • 15 Smillie RP, Shetty M, Boyer AC, Madrazo B, Jafri SZ. Imaging evaluation of the inferior vena cava. Radiographics 2015; 35 (02) 578-592
  • 16 Oblitas CM, García-García A, Galeano-Valle F. et al. Long-term anticoagulant treatment in patients with inferior vena cava agenesis and deep vein thrombosis. Thromb Res 2020; 196: 305-307
  • 17 Tarazi M, Bashir A, Khan K, Kakani N, Murray D, Serracino-Inglott F. A literature review and case series of DVT patients with absent IVC treated with thrombolysis. Ann Vasc Surg 2020; 67: 521-531
  • 18 Sagban TA, Grotemeyer D, Balzer KM. et al. Surgical treatment for agenesis of the vena cava: a single-centre experience in 15 cases. Eur J Vasc Endovasc Surg 2010; 40 (02) 241-245
  • 19 Scali ST, Beck AW, DeMartino RD, Duxbury A, Walsh DB. Endovascular management of congenital atresia of the infrarenal IVC. Vasc Endovascular Surg 2010; 44 (03) 234-236
  • 20 Porter D, Rundback JH, Miller S. Sharp recanalization using a subintimal reentry device, angioplasty, and stent placement for severely symptomatic iliofemoral deep venous thrombosis secondary to congenital aplasia of the inferior vena cava. J Vasc Interv Radiol 2010; 21 (11) 1765-1769
  • 21 Haskal ZJ, Potosky DR, Twaddell WS. Percutaneous endovascular creation of an inferior vena cava in a patient with caval agenesis, Budd-Chiari syndrome, and iliofemorocaval thrombosis. J Vasc Interv Radiol 2014; 25 (01) 63-69
  • 22 Schiffman MH, Cornman-Homonoff J, Sos TA. Percutaneous orthotopic IVC construction in a pediatric patient with symptomatic IVC agenesis. Cardiovasc Intervent Radiol 2019; 42 (02) 308-312
  • 23 Homans J. Exploration and division of the femoral and iliac veins in the treatment of thrombophlebitis of the leg. N Engl J Med 1941; 224 (05) 179-186
  • 24 Homans J. Diseases of the veins. N Engl J Med 1946; 235 (05) 163-167
  • 25 Ochsner A, Ochsner JL, Sanders HS. Prevention of pulmonary embolism by caval ligation. Ann Surg 1970; 171 (06) 923-938
  • 26 Sullivan PS, Dente CJ, Patel S. et al. Outcome of ligation of the inferior vena cava in the modern era. Am J Surg 2010; 199 (04) 500-506
  • 27 Spencer FC, Quattlebaum JK, Quattlebaum Jr JK, Sharp EH, Jude JR. Plication of the inferior vena cava for pulmonary embolism: a report of 20 cases. Ann Surg 1962; 155 (06) 827-837
  • 28 Moretz WH, Rhode CM, Shepherd MH. Prevention of pulmonary emboli by partial occlusion of the inferior vena cava. Am Surg 1959; 25: 617-626
  • 29 Miles RM, Chappell F, Renner O. A partially occluding vena caval clip for prevention of pulmonary embolism. Am Surg 1964; 30: 40-47
  • 30 Adams JT, Feingold BE, DeWeese JA. Comparative evaluation of ligation and partial interruption of the inferior vena cava. Arch Surg 1971; 103 (02) 272-276
  • 31 Naqvi SY, Raza M, McCormick DJ. Severe lower extremity edema caused by inferior vena cava metallic clip and enlarged uterine fibroids. JACC Cardiovasc Interv 2016; 9 (19) e197-e198
  • 32 O'Donnell ME, Coan KE, Naidu SG, Shamoun FE, Money SR. Percutaneous thrombolysis of acute-on-chronic inferior vena cava thrombosis after previous insertion of an Adams-DeWeese clip. Vasc Endovascular Surg 2014; 48 (04) 342-345
  • 33 Mobin-Uddin K, Jude JR. Intracaval prosthesis for prevention of pulmonary embolism. Br J Surg 1969; 56 (08) 620
  • 34 Grassi CJ, Goldhaber SZ. Interruption of the inferior vena cava for prevention of pulmonary embolism: transvenous filter devices. Herz 1989; 14 (03) 182-191
  • 35 Greenfield LJ. Evolution of venous interruption for pulmonary thromboembolism. Arch Surg 1992; 127 (05) 622-626
  • 36 Winokur RS, Bassik N, Madoff DC, Trost D. Radiologists' field guide to permanent inferior vena cava filters. AJR Am J Roentgenol 2019; 213 (04) 762-767
  • 37 Winokur RS, Bassik N, Madoff DC, Trost D. Radiologists' field guide to retrievable and convertible inferior vena cava filters. AJR Am J Roentgenol 2019; 213 (04) 768-777
  • 38 Taccone FS, Bunker N, Waldmann C. et al. A new device for the prevention of pulmonary embolism in critically ill patients: results of the European Angel Catheter Registry. J Trauma Acute Care Surg 2015; 79 (03) 456-462
  • 39 Elizondo G, Eggers M, Falcon M. et al. First-in-human study with eight patients using an absorbable vena cava filter for the prevention of pulmonary embolism. J Vasc Interv Radiol 2020; 31 (11) 1817-1824
  • 40 Saeed MJ, Turner TE, Brown DL. Trends in inferior vena cava filter placement by indication in the United States From 2005 to 2014. JAMA Intern Med 2017; 177 (12) 1861-1862
  • 41 Reddy S, Lakhter V, Zack CJ, Zhao H, Chatterjee S, Bashir R. Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration Advisory. JAMA Intern Med 2017; 177 (09) 1373-1374
  • 42 Bikdeli B, Wang Y, Jimenez D. et al. Association of inferior vena cava filter use with mortality rates in older adults with acute pulmonary embolism. JAMA Intern Med 2019; 179 (02) 263-265
  • 43 Glocker RJ, TerBush MJ, Hill EL. et al. Bundling of reimbursement for inferior vena cava filter placement resulted in significantly decreased utilization between 2012 and 2014. Ann Vasc Surg 2017; 38: 172-176
  • 44 Curtis RM, Vogt K, Parry N. et al. Retrievable inferior vena cava filter for primary prophylaxis of pulmonary embolism in at-risk trauma patients: a feasibility trial. Injury 2021; 52 (05) 1210-1214
  • 45 Haskins IN, Rivas L, Ju T. et al. The association of IVC filter placement with the incidence of postoperative pulmonary embolism following laparoscopic bariatric surgery: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Project. Surg Obes Relat Dis 2019; 15 (01) 109-115
  • 46 Ho KM, Rao S, Honeybul S. et al. A multicenter trial of vena cava filters in severely injured patients. N Engl J Med 2019; 381 (04) 328-337
  • 47 Malgor RD, Labropoulos N. A systematic review of symptomatic duodenal perforation by inferior vena cava filters. J Vasc Surg 2012; 55 (03) 856-861.e3
  • 48 Gillespie DL, Spies JB, Siami FS, Rectenwald JE, White RA, Johnson MS. Predicting the safety and effectiveness of inferior vena cava filters study: design of a unique safety and effectiveness study of inferior vena cava filters in clinical practice. J Vasc Surg Venous Lymphat Disord 2020; 8 (02) 187-194.e1
  • 49 Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort. J Am Heart Assoc 2017; 6 (09) e006708
  • 50 Jaff MR, McMurtry MS, Archer SL. et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, American Heart Association Council on Peripheral Vascular Disease, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
  • 51 Kaufman JA, Barnes GD, Chaer RA. et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol 2020; 31 (10) 1529-1544
  • 52 Kearon C, Akl EA, Comerota AJ. et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) e419S-e496S
  • 53 Kearon C, Akl EA, Ornelas J. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (02) 315-352
  • 54 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
  • 55 Mazzolai L, Aboyans V, Ageno W. et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J 2018; 39 (47) 4208-4218
  • 56 Wang SL, Cha HH, Lin JR. et al. Impact of physician education and a dedicated inferior vena cava filter tracking system on inferior vena cava filter use and retrieval rates across a large US health care region. J Vasc Interv Radiol 2016; 27 (05) 740-748
  • 57 Aurshina A, Brahmandam A, Zhang Y. et al. Patient perspectives on inferior vena cava filter retrieval. J Vasc Surg Venous Lymphat Disord 2019; 7 (04) 507-513
  • 58 Ko SH, Reynolds BR, Nicholas DH. et al. Institutional protocol improves retrievable inferior vena cava filter recovery rate. Surgery 2009; 146 (04) 809-814 , discussion 814–816
  • 59 Minocha J, Idakoji I, Riaz A. et al. Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic. J Vasc Interv Radiol 2010; 21 (12) 1847-1851
  • 60 Lee MJ, Valenti D, de Gregorio MA, Minocha J, Rimon U, Pellerin O. The CIRSE retrievable IVC filter registry: retrieval success rates in practice. Cardiovasc Intervent Radiol 2015; 38 (06) 1502-1507
  • 61 PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112 (03) 416-422
  • 62 King RW, Wooster MD, Veeraswamy RK, Genovese EA. Contemporary rates of inferior vena cava filter thrombosis and risk factors. J Vasc Surg Venous Lymphat Disord 2022; 10 (02) 313-324
  • 63 Molvar C. Inferior vena cava filtration in the management of venous thromboembolism: filtering the data. Semin Intervent Radiol 2012; 29 (03) 204-217
  • 64 Chick JFB, Jo A, Meadows JM. et al. endovascular iliocaval stent reconstruction for inferior vena cava filter-associated iliocaval thrombosis: approach, technical success, safety, and two-year outcomes in 120 patients. J Vasc Interv Radiol 2017; 28 (07) 933-939
  • 65 Vedantham S, Vesely TM, Parti N. et al. Endovascular recanalization of the thrombosed filter-bearing inferior vena cava. J Vasc Interv Radiol 2003; 14 (07) 893-903
  • 66 Ko H, Ahn S, Min S, Hur S, Jae HJ, Min SK. Recanalization of an occluded vena cava filter and iliac veins with kissing stents to treat postthrombotic syndrome with a venous stasis ulcer. Vasc Spec Int 2020; 36 (02) 116-121
  • 67 Andreoli JM, Lewandowski RJ, Vogelzang RL, Ryu RK. Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol 2014; 25 (08) 1181-1185
  • 68 Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000; 216 (01) 54-66
  • 69 Greenfield LJ, Proctor MC. Suprarenal filter placement. J Vasc Surg 1998; 28 (03) 432-438 , discussion 438
  • 70 Matchett WJ, Jones MP, McFarland DR, Ferris EJ. Suprarenal vena caval filter placement: follow-up of four filter types in 22 patients. J Vasc Interv Radiol 1998; 9 (04) 588-593
  • 71 Stewart JR, Peyton JW, Crute SL, Greenfield LJ. Clinical results of suprarenal placement of the Greenfield vena cava filter. Surgery 1982; 92 (01) 1-4
  • 72 Baheti A, Sheeran D, Patrie J, Sabri SS, Angle JF, Wilkins LR. Suprarenal inferior vena cava filter placement and retrieval: safety analysis. J Vasc Interv Radiol 2020; 31 (02) 231-235
  • 73 Kalva SP, Chlapoutaki C, Wicky S, Greenfield AJ, Waltman AC, Athanasoulis CA. Suprarenal inferior vena cava filters: a 20-year single-center experience. J Vasc Interv Radiol 2008; 19 (07) 1041-1047
  • 74 Ascer E, Gennaro M, Lorensen E, Pollina RM. Superior vena caval Greenfield filters: indications, techniques, and results. J Vasc Surg 1996; 23 (03) 498-503
  • 75 Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep vein thrombosis of the upper extremity. Dtsch Arztebl Int 2017; 114 (14) 244-249
  • 76 Usoh F, Hingorani A, Ascher E. et al. Long-term follow-up for superior vena cava filter placement. Ann Vasc Surg 2009; 23 (03) 350-354
  • 77 Lopera JE, Barnes L. A single center 10-year clinical experience with superior vena cava retrievable filters. Catheter Cardiovasc Interv 2020; 95 (01) 1-6
  • 78 Bikdeli B, Kirtane AJ, Jimenez D. et al. Hemopericardium and cardiac tamponade as a complication of vena caval filters: systematic review of the published literature and the MAUDE database. Clin Appl Thromb Hemost 2019; 25: 1076029619849111
  • 79 Ramchandani P, Zeit RM, Koolpe HA. Bilateral iliac vein filtration. An effective alternative to caval filtration in patients with megacava. Arch Surg 1991; 126 (03) 390-393
  • 80 Van Ha TG, Dillon P, Funaki B. et al. Use of retrievable filters in alternative common iliac vein location in high-risk surgical patients. J Vasc Interv Radiol 2011; 22 (03) 325-329
  • 81 Anderson DR, Morgano GP, Bennett C. et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 2019; 3 (23) 3898-3944
  • 82 Kaufman JA, Kinney TB, Streiff MB. et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol 2006; 17 (03) 449-459
  • 83 Mazzolai L, Ageno W, Alatri A. et al. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function. Eur J Prev Cardiol 2022; 29 (08) 1248-1263
  • 84 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) e278S-e325S
  • 85 Gould MK, Garcia DA, Wren SM. et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) e227S-e277S
  • 86 Mismetti P, Laporte S, Pellerin O. et al; PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 2015; 313 (16) 1627-1635
  • 87 Key NS, Khorana AA, Kuderer NM. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2020; 38 (05) 496-520
  • 88 Streiff MB, Holmstrom B, Angelini D. et al. Cancer-associated venous thromboembolic disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021; 19 (10) 1181-1201
  • 89 Comes RF, Mismetti P, Afshari A. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: inferior vena cava filters. Eur J Anaesthesiol 2018; 35 (02) 108-111
  • 90 Mechanick JI, Apovian C, Brethauer S. et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis 2020; 16 (02) 175-247
  • 91 Pepke-Zaba J, Delcroix M, Lang I. et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124 (18) 1973-1981
  • 92 Grieff AN, Shafritz R, Beckerman WE. Extravascular reconstruction of a congenitally absent inferior vena cava. J Vasc Surg Cases Innov Tech 2020; 6 (04) 681-685
  • 93 Konstantinides SV, Torbicki A, Agnelli G. et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
  • 94 Ortel TL, Neumann I, Ageno W. et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020; 4 (19) 4693-4738
  • 95 Giri J, Sista AK, Weinberg I. et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation 2019; 140 (20) e774-e801
  • 96 McCormack T, Harrisingh MC, Horner D, Bewley S. Guideline Committee. Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing. BMJ 2020; 369: m1565
  • 97 Kakkos SK, Gohel M, Baekgaard N. et al; Esvs Guidelines Committee. Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 2021; 61 (01) 9-82
  • 98 Minocha J, Smith AM, Kapoor BS. et al; Expert Panel on Interventional Radiology. ACR Appropriateness Criteria® radiologic management of venous thromboembolism-inferior vena cava filters. J Am Coll Radiol 2019; 16 (5S, 5s): S214-S226
  • 99 Borrero E, Rosenthal D. Inferior vena cava interruption for the prevention of pulmonary emboli: advantages, disadvantages, and complications. Vasc Surg 1991; 25 (06) 421-432
  • 100 Chand R, Eltorai AE, Healey T, Ahn S. Essential Interventional Radiology Review: A Question and Answer Guide. Berlin: Springer Nature;; 2021
  • 101 Jia Z, Wu A, Tam M, Spain J, McKinney JM, Wang W. Caval penetration by inferior vena cava filters: a systematic literature review of clinical significance and management. Circulation 2015; 132 (10) 944-952
  • 102 Dake MD, Murphy TP, Krämer AH. et al; SENTRY Trial Investigators. One-year analysis of the prospective multicenter SENTRY clinical trial: safety and effectiveness of the novate sentry bioconvertible inferior vena cava filter. J Vasc Interv Radiol 2018; 29 (10) 1350-1361.e4
  • 103 Lorch H, Welger D, Wagner V. et al. Current practice of temporary vena cava filter insertion: a multicenter registry. J Vasc Interv Radiol 2000; 11 (01) 83-88
  • 104 Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med 2011; 124 (07) 655-661
  • 105 Wang SL, Lloyd AJ. Clinical review: inferior vena cava filters in the age of patient-centered outcomes. Ann Med 2013; 45 (07) 474-481